A newly approved pill nearly doubled median survival by blocking a cancer-driving protein once considered “undruggable.” Daraxonrasib, sold as Rasonque, is the first FDA-approved oral RAS inhibitor ...
The investment seeks to provide a high current yield exempt from federal income tax; growth of capital may also be considered. The fund normally invests at least 80% of assets in municipal securities ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results